Mitochondrial-Targeted Peptides
MOTS-c
Animal studiesNot approved for human use in the US
Last reviewed: 2026-11-19
Evidence status & limitations
Observational measurements of natural MOTS-c do not establish efficacy of external MOTS-c; clinical trials of modified analogs are not trials of this exact peptide.
Regulatory status
No FDA-approved human medicine for this exact identity was established in this review. Investigational research is not approval.
Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.
WADA prohibited status: current list and contextKnown risks & open questions
Reliable human intervention safety and long-term outcomes remain unestablished.
Key sources
Primary-reference and editorial check: November 19, 2026. Not an exhaustive clinical review; exact formulations and populations matter.
Related compounds
- Elamipretide
Same scientific class · A 4-amino-acid chain. · FDA-approved for specific indications